Related references
Note: Only part of the references are listed.SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer's Disease?
Dhanya Krishnan et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)
delta-Secretase-cleaved Tau stimulates A beta production via upregulating STAT1-BACE1 signaling in Alzheimer's disease
Zhentao Zhang et al.
MOLECULAR PSYCHIATRY (2021)
Recent Advances in the Development of Casein Kinase 1 Inhibitors
Sha-Sha Li et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model
Xu-Qiao Chen et al.
ALZHEIMERS & DEMENTIA (2021)
TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer's disease pathologies
Yiyuan Xia et al.
MOLECULAR PSYCHIATRY (2021)
First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer's Disease
Benjamin Guieu et al.
MOLECULES (2021)
Role of Notch signaling in neurovascular aging and Alzheimer's disease
Arunima Kapoor et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
Nicholas J. Izzo et al.
ALZHEIMERS & DEMENTIA (2021)
Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial
Yuji Koriyama et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice
Yanxing Chen et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Mitochondrial ubiquitin ligase alleviates Alzheimer's disease pathology via blocking the toxic amyloid-β oligomer generation
Keisuke Takeda et al.
COMMUNICATIONS BIOLOGY (2021)
A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies
Yinan Yao et al.
BRAIN (2021)
Amyloid β Clearance Is Disrupted by Depletion of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytes
Javier Cavieres-Lepe et al.
JOURNAL OF NEUROSCIENCE (2021)
GDE2-RECK controls ADAM10 α-secretase-mediated cleavage of amyloid precursor protein
Mai Nakamura et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Dichlorodiphenyltrichloroethane Impairs Amyloid Beta Clearance by Decreasing Liver X Receptor α Expression
Dongmei Wu et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Netrin-1 receptor UNC5C cleavage by active δ-secretase enhances neurodegeneration, promoting Alzheimer's disease pathologies
Guiqin Chen et al.
SCIENCE ADVANCES (2021)
Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer's disease-related pathologies in a senescence-accelerated mouse model
Ju Wang et al.
TRANSLATIONAL NEURODEGENERATION (2021)
Alzheimer's disease neuropathological change three decades after iatrogenic amyloid-β transmission
Zane Jaunmuktane et al.
ACTA NEUROPATHOLOGICA (2021)
The Problem of Aducanumab for the Treatment of Alzheimer Disease
G. Caleb Alexander et al.
ANNALS OF INTERNAL MEDICINE (2021)
Critical Appraisal of Amyloid Lowering Agents in AD
Boris Decourt et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2021)
Dysregulated APP expression and α-secretase processing of APP is involved in manganese-induced cognitive impairment
Yiping Yang et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2021)
NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
Giulia Sita et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease
Mariana Van Zeller et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
FDA approval for Biogen's aducanumab sparks Alzheimer disease firestorm
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Alzheimer's disease drug development pipeline: 2021
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)
BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
Nour M. Moussa-Pacha et al.
MEDICINAL RESEARCH REVIEWS (2020)
Progress in Target Drug Molecules for Alzheimer's Disease
Jiayang Xie et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer's Disease
Md Sahab Uddin et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease
Balmiki Ray et al.
TRANSLATIONAL PSYCHIATRY (2020)
Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials
Anna Hung et al.
Journal of Managed Care & Specialty Pharmacy (2020)
Astrocytes deliver CK1 to neurons via extracellular vesicles in response to inflammation promoting the translation and amyloidogenic processing of APP
Zhigang Li et al.
JOURNAL OF EXTRACELLULAR VESICLES (2020)
ABAD/17β-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP/PS1 mice
Xiaodan Xiao et al.
NEUROBIOLOGY OF AGING (2019)
Lowering of Amyloid-Beta by β-Secretase Inhibitors - Some Informative Failures
David S. Knopman
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Decreased Netrin-1 and Correlated Th17/Tregs Balance Disorder in Aβ1-42 Induced Alzheimer's Disease Model Rats
Lina Sun et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
The rights of precision drug development for Alzheimer's disease
Jeffrey Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer's Disease
Mehjabeen Naushad et al.
PLANTA MEDICA (2019)
Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease
Ahmed Morsy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
AUTACs: Cargo-Specific Degraders Using Selective Autophagy
Daiki Takahashi et al.
MOLECULAR CELL (2019)
Alzheimer's disease drug development pipeline: 2019
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice
Zhenri Ou et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders
Ondrej Benek et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Alzheimer's disease research: the future of BACE inhibitors
Talha Burki
LANCET (2018)
The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer's disease
Chun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Metabolic Syndrome and Amyloid Accumulation in the Aging Brain
Gabriela Gomez et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Transcriptomic and morphophysiological evidence for a specialized human cortical GABAergic cell type
Eszter Boldog et al.
NATURE NEUROSCIENCE (2018)
Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease
Charbel E-H. Moussa
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
PTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer's disease pathogenesis (Publication with Expression of Concern. See vol. 113, pg. 152, 2022)
Hoau-Yan Wang et al.
NEUROBIOLOGY OF AGING (2017)
Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease
Zhentao Zhang et al.
NATURE COMMUNICATIONS (2017)
Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment
Lukas Hroch et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II
F. E. Matthews et al.
NATURE COMMUNICATIONS (2016)
Safety and tolerability of BAN2401-a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody
Veronika Logovinsky et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Alzheimer's Disease: Mechanism and Approach to Cell Therapy
Takashi Amemori et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
APP intracellular domain-WAVE1 pathway reduces amyloid-β production
Ilaria Ceglia et al.
NATURE MEDICINE (2015)
Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25-35 peptide-injected mice, a nontransgenic Alzheimer's disease model
Valentine Lahmy et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease
Zhentao Zhang et al.
NATURE COMMUNICATIONS (2015)
Anti-amyloidogenic effects of ID1201, the ethanolic extract of the fruits of Melia toosendan, through activation of the phosphatidylinositol 3-kinase/Akt pathway
Hanbyeol Park et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2014)
Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance
Irina Lonskaya et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer's disease (Review)
Zhiyou Cai
MOLECULAR MEDICINE REPORTS (2014)
Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models
Irina Lonskaya et al.
MOLECULAR NEURODEGENERATION (2014)
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
Zhentao Zhang et al.
NATURE MEDICINE (2014)
ID1201, the ethanolic extract of the fruit of Melia toosendan ameliorates impairments in spatial learning and reduces levels of amyloid beta in 5XFAD mice
Woo-Hyun Cho et al.
NEUROSCIENCE LETTERS (2014)
Antiamyloid Therapy for Alzheimer's Disease - Are We on the Right Road?
Eric Karran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Metal protein attenuating compounds for the treatment of Alzheimer's dementia
Elizabeth L. Sampson et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance
Irina Lonskaya et al.
EMBO MOLECULAR MEDICINE (2013)
Alpha-Secretase Cleavage of the Amyloid Precursor Protein: Proteolysis Regulated by Signaling Pathways and Protein Trafficking
Stefan F. Lichtenthaler
Current Alzheimer Research (2012)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
β-Amyloid burden in healthy aging Regional distribution and cognitive consequences
K. M. Rodrigue et al.
NEUROLOGY (2012)
Lifelong Management of Amyloid-Beta Metabolism to Prevent Alzheimer's Disease
Sam Gandy
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation
Demian Obregon et al.
NATURE COMMUNICATIONS (2012)
Multi-Target-Directed Ligands in Alzheimer's Disease Treatment
M. Bajda et al.
CURRENT MEDICINAL CHEMISTRY (2011)
The evolution of the brain, the human nature of cortical circuits, and intellectual creativity
Javier DeFelipe
FRONTIERS IN NEUROANATOMY (2011)
ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons
Peer-Hendrik Kuhn et al.
EMBO JOURNAL (2010)
The Disintegrin/Metalloproteinase ADAM10 Is Essential for the Establishment of the Brain Cortex
Ellen Jorissen et al.
JOURNAL OF NEUROSCIENCE (2010)
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
Sung-Wuk Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Netrin-1 interacts with amyloid precursor protein and regulates amyloid-beta production
F. C. Lourenco et al.
CELL DEATH AND DIFFERENTIATION (2009)
Uniquely Hominid Features of Adult Human Astrocytes
Nancy Ann Oberheim et al.
JOURNAL OF NEUROSCIENCE (2009)
Brain-Derived Neurotrophic Factor Reduces Amyloidogenic Processing through Control of SORLA Gene Expression
Michael Rohe et al.
JOURNAL OF NEUROSCIENCE (2009)
Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1
Nassima Oumata et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Therapeutics for Alzheimer's disease based on the Metal Hypothesis
Ashley I. Bush et al.
NEUROTHERAPEUTICS (2008)
Inhibition of protein phosphatases induces transport deficits and axonopathy
Ying Yang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Imaging β-amyloid burden in aging and dementia
C. C. Rowe et al.
NEUROLOGY (2007)
Cellular scaling rules for rodent brains
Suzana Herculano-Houzel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The neuropeptide PACAP promotes alpha-secretase pathway for processing Alzheimer amyloid precursor protein
E Kojro et al.
FASEB JOURNAL (2006)
Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism
Y Porat et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Molecular insights into human brain evolution
RS Hill et al.
NATURE (2005)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Changes in acetylcholine extracellular levels during cognitive processes
G Pepeu et al.
LEARNING & MEMORY (2004)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine
S Ando et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Share Paper
